Invatech Health is a technology company specializing in health and social care, offering medicines management solutions for care homes and pharmacies. The company's flagship products, ATLAS eMAR and TITAN PMR, cater to the specific needs of these settings. Founded in 2014 and headquartered in the United Kingdom, Invatech Health focuses on developing practical solutions for the healthcare sector, with a particular emphasis on addressing unmet needs in areas such as mental health and domiciliary care.
One notable milestone for Invatech Health is their acquisition of the Intellectual Property rights to the Proactive Care System (PCS) developed at Pharmacy Plus. This system, which has already demonstrated effectiveness in over 600 care home sites in the UK, aligns with the company's mission to provide innovative electronic medicines management solutions. Additionally, with over 90,000 patients having received medication via PCS and the training of over 20,000 staff on its use, Invatech Health is positioned to make a significant impact in enhancing medication management within the care sector.
In terms of investment, Invatech Health received a £900.00K grant investment from Innovate UK on 29 January 2021, demonstrating recognition and support from an esteemed investor in the field. With their focus on leveraging technology to improve healthcare, Invatech Health presents a compelling opportunity for investment in the rapidly evolving health and information technology sectors.